Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesPharmacy & Specialty DrugsIndependent Health step therapy Coverage Update | …
    Ask Trek AI about this page
    CurrentIndependent HealthPolicy N/A

    Step therapy criteria for Child Health Plus formulary medications

    Customize your policy alerts

    Sign up for all Independent Health policy alerts

    Know when Independent Health releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Defines step therapy rules that require trying specified medications or demonstrating prior medication history before covering certain formulary drugs for Independent Health Child Health Plus members.

    Policy Summary
    PayerIndependent Health
    PolicyStep therapy criteria for Child Health Plus formulary medications
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateJun 1, 2026
    Next Review DateN/A
    Key ActionUse the patient's Independent Health pharmacy history to confirm required prior fills or concurrent therapies to allow online processing and avoid prior authorization.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    20+
    listed products
    16+drug presentations
    rangelookback window
    120dUbrelvy window
    90dUloric window
    NCstate

    Coverage Criteria — Step Therapy and Formulary Rules

    Entacapone coverage criteria

    Entacapone

    Entacapone online pass condition: Prescription goes through online IF pharmacy history documents concurrent use of carbidopa/levodopa.concurrent use

    If not met, prior authorization required

    Desonide coverage criteria

    Desonide 0.05% external

    Desonide prior therapy: Prescription goes through online IF pharmacy history documents that alclometasone was filled within the previous 90 days.90 days

    If not met, prior authorization required

    Aprepitant coverage criteria

    Aprepitant

    Aprepitant prior dexamethasone: Prescription goes through online IF pharmacy history documents at least a five-day supply of dexamethasone filled within the previous 90 days.>=5 days within 90 days

    If not met, prior authorization required

    Eucrisa coverage criteria

    Eucrisa

    Eucrisa prior topical therapy: Prescription goes through online IF pharmacy history documents prior use of a topical corticosteroid or a topical calcineurin inhibitor (e.g., pimecrolimus, tacrolimus) within the previous 365 days.365 days

    If not met, prior authorization required

    Granisetron coverage criteria

    Granisetron

    Granisetron ondansetron requirement: Prescription goes through online IF pharmacy history documents that ondansetron was filled within the previous 180 days.180 days

    If not met, prior authorization required

    Opioid/fentanyl coverage criteria

    Opioid ER and fentanyl patches

    Opioid prior narcotic fills: Prescription goes through online IF pharmacy history documents that narcotic medications were filled within the previous 120 days.120 days

    If not met, prior authorization required

    Aliskiren coverage criteria

    Aliskiren

    Aliskiren ACE and ARB fills: Prescription goes through online IF pharmacy history documents that an ACE inhibitor AND an ARB were filled within the previous 90 days.90 days

    If not met, prior authorization required

    Serevent coverage criteria

    Serevent Diskus

    Serevent concurrent therapy: Prescription goes through online IF pharmacy history documents concurrent use of an inhaled corticosteroid OR Spiriva.concurrent use

    If not met, prior authorization required

    Ubrelvy coverage criteria

    Ubrelvy

    Ubrelvy triptan prior fill: Prescription goes through online IF pharmacy history documents that a generic triptan product was filled within the previous 120 days.120 days

    If not met, prior authorization required

    Ubrelvy

    Ubrelvy routing criteria

    Prior triptan fill: Pharmacy profile must show a generic triptan (e.g., sumatriptan, naratriptan, rizatriptan) filled within the previous 120 days to process Ubrelvy online; if not, prior authorization is required.120 days

    Uloric (febuxostat)

    Uloric (febuxostat) routing criteria

    Prior allopurinol fill: Pharmacy profile must show an allopurinol fill within the previous 90 days to process febuxostat (Uloric) online; if not, prior authorization is required.90 days

    This step therapy list applies specifically to Independent Health's Child Health Plus formulary and is current as of 6/1/2026. The formulary and associated protocols may change; members will receive notice of changes. For questions, providers or pharmacists may contact Member Services at the phone numbers shown in the formulary excerpt.

    The provided excerpt contains an index of covered product presentations (e.g., multiple pen/auto‑injector and tablet strengths) but does not list explicit exclusions. No medications or indications are identified in this partial extract as being specifically excluded from coverage.

    Coding, Lookback Windows, and Drug Presentation Index

    Indexed drug presentationsmixed
    15 MG/0.5MLMOUNJARO SOLUTION AUTO-INJECTOR 15 MG/0.5ML (listed repeatedly as index entry)
    0.25 OR 0.5 MG/DOSEOZEMPIC SOLUTION PEN-INJECTOR (0.25 or 0.5 mg/dose) SUBCUTANEOUS
    1 MG/DOSEOZEMPIC SOLUTION PEN-INJECTOR (1 mg/dose) SUBCUTANEOUS
    2 MG/DOSEOZEMPIC SOLUTION PEN-INJECTOR (2 mg/dose) SUBCUTANEOUS
    14 MGRYBELSUS TABLET 14 MG ORAL
    3 MGRYBELSUS TABLET 3 MG ORAL
    7 MGRYBELSUS TABLET 7 MG ORAL
    50 MCG/ACTSEREVENT DISKUS AEROSOL POWDER BREATH ACTIVATED 50 MCG/ACT INHALATION
    0.75 MG/0.5MLTRULICITY SOLUTION AUTO-INJECTOR 0.75 MG/0.5ML SUBCUTANEOUS
    1.5 MG/0.5MLTRULICITY SOLUTION AUTO-INJECTOR 1.5 MG/0.5ML SUBCUTANEOUS
    1–10 of 14
    1/2
    GLP-1 prior medication lookback
    Lookback window130 days
    TriggerPharmacy history must document type 2 diabetes OR a filled oral antidiabetic (excluding metformin)
    Action if not metPrior authorization required
    Entacapone concurrent medication requirement
    RequirementConcurrent use of carbidopa/levodopa documented in pharmacy history
    Days specifiedNo specific lookback window specified
    Action if not met

    Provider Actions, Prior Authorization Triggers, and Documentation

    Prior Authorization

    GLP-1 Prior Authorization

    Prior Authorization Required: A prescription for an antidiabetic GLP-1 medication is processed automatically if the patient's Independent Health prescription history documents type 2 diabetes or records that the patient has tried any oral antidiabetic drug (excluding metformin) within the past 130 days. If the pharmacy profile does not meet this criterion, prior authorization is required.

    • Products affected include multiple GLP-1 agents (e.g., Mounjaro, Ozempic, Rybelsus, Trulicity) as listed in the index/product presentations.
    • Pharmacy must reference the member's Independent Health prescription history to determine if the trigger criteria are met.
    • If history does not document the required diagnosis or prior oral antidiabetic use (excluding metformin) within 130 days, submit a prior authorization request.
    Step Therapy

    GLP-1 Step Therapy Rule

    Step Therapy Rule: Certain GLP-1 products are subject to step therapy protocols as part of Independent Health's formulary. The prescriber and pharmacy should confirm whether an ST designation applies in the member's formulary and follow required trial steps before coverage of a nonpreferred GLP-1 agent is authorized.

    Initial Therapy — Online Pass / Prior Authorization Conditions

    GLP-1 initial therapy

    GLP-1 agents pass online with documented prior oral antidiabetic or diagnosis

    GLP-1 initial: Patient must have type 2 diabetes documented or a filled oral antidiabetic (excluding metformin) within 130 days to avoid prior authorization.130 days

    Applies to listed GLP-1 products

    Ubrelvy initial therapy requirement

    Step: try generic triptan: Evidence of a generic triptan fill within 120 days is required in pharmacy history before Ubrelvy will route online.120 days

    Examples listed: sumatriptan, naratriptan, rizatriptan.

    Step Therapy Steps, Lookback Windows, and Required Prior Fills

    RequirementLookback / windowProvider action to avoid prior authorization
    Documented type 2 diabetes or prior oral antidiabetic (excluding metformin)
    130 days
    Ensure Independent Health prescription history shows diagnosis of type 2 diabetes or a filled oral antidiabetic (not metformin) within past 130 days
    Coverage requirementLookback / windowProvider action to avoid prior authorization
    Evidence of prior generic triptan fill (e.g., sumatriptan, naratriptan, rizatriptan)
    120 days
    Confirm Independent Health prescription history documents a generic triptan filled within the previous 120 days before submitting Ubrelvy
    Coverage requirementLookback / windowProvider action to avoid prior authorization
    Evidence of prior allopurinol fill
    90 days
    Ensure Independent Health prescription history shows an allopurinol fill within the previous 90 days before submitting febuxostat (Uloric)
    PresentationForm / strength as listed in indexNotes
    MOUNJARO
    15 MG/0.5ML solution auto-injector (also other strengths listed)
    Indexed as multiple auto-injector presentations in policy index
    OZEMPIC
    0.25 or 0.5 mg/dose; 1 mg/dose; 2 mg/dose solution pen-injector
    Multiple pen strengths listed in index
    RYBELSUS
    Tablets: 3 mg, 7 mg, 14 mg
    Listed as oral tablet presentations in index
    TRULICITY
    Auto-injector: 0.75, 1.5, 3, 4.5 mg/0.5 mL
    Multiple auto-injector strengths listed
    SEREVENT DISKUS
    Aerosol powder breath activated 50 MCG/ACT inhalation
    Listed in index; routing criteria elsewhere in policy
    UBRELVY
    Tablets: 50 mg, 100 mg
    Indexed presentations for ubrogepant

    Background and Rationale

    Step therapy is a utilization-management approach that requires a patient to try specified first-line or established therapies before a different medication will be covered. In this formulary, step therapy protocols are used to promote clinically appropriate, cost-effective prescribing (for example, trying an established generic before a brand-name agent) and to ensure required concurrent therapies are used when indicated. Medications subject to step therapy are noted with an 'ST' on the formulary, and pharmacy history or documented prior fills are used to determine whether a prescription will route online or require prior authorization.

    Definitions and Terms

    Step therapy definition
    DefinitionStep therapy is a utilization management approach that requires trying first-line or established therapies or demonstrating prior medication use before covering alternative medications
    PurposeHelps ensure effective, lower-cost, or appropriately combined therapies are used before covering alternative treatments
    Patient notice & contactFormulary may change; contact Member Services (716-250-7183 or 1-833-891-9372) with questions
    concurrent use definition
    DefinitionConcurrent use documented in pharmacy history (e.g., inhaled corticosteroid or Spiriva for Serevent)
    ApplicationUsed to determine online routing vs prior authorization when concurrent therapy is required
    Policy Summary
    PayerIndependent Health
    PolicyStep therapy criteria for Child Health Plus formulary medications
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateJun 1, 2026
    Next Review DateN/A
    Key ActionUse the patient's Independent Health pharmacy history to confirm required prior fills or concurrent therapies to allow online processing and avoid prior authorization.
    SourceLink
    On This Page
    Coverage Criteria — Step Therapy and Formulary RulesCoding, Lookback Windows, and Drug Presentation IndexProvider Actions, Prior Authorization Triggers, and DocumentationInitial Therapy — Online Pass / Prior Authorization ConditionsStep Therapy Steps, Lookback Windows, and Required Prior FillsBackground and RationaleDefinitions and Terms
    Prior authorization required
    Desonide prior use lookback
    Lookback window90 days
    Required prior fillAlclometasone documented in pharmacy history
    Action if not metPrior authorization required
    Aprepitant prior dexamethasone lookback
    Lookback window90 days
    Required prior supplyAt least a five-day supply of dexamethasone documented in pharmacy history
    Action if not metPrior authorization required
    Eucrisa prior therapy lookback
    Lookback window365 days
    Required prior therapyPrior use of a topical corticosteroid or topical calcineurin inhibitor (e.g., pimecrolimus, tacrolimus) documented in pharmacy history
    Action if not metPrior authorization required
    Granisetron ondansetron lookback
    Lookback window180 days
    Required prior fillOndansetron documented in pharmacy history
    Action if not metPrior authorization required
    Opioid/narcotic lookback
    Lookback window120 days
    Required prior fillsNarcotic medications documented in pharmacy history
    Action if not metPrior authorization required
    Aliskiren ACE/ARB lookback
    Lookback window90 days
    Required prior fillsAn ACE inhibitor AND an ARB documented in pharmacy history (examples: lisinopril, enalapril; losartan, irbesartan)
    Action if not metPrior authorization required
    Ubrelvy triptan lookback
    Lookback window120 days
    Required prior fillA generic triptan product (e.g., sumatriptan, naratriptan, rizatriptan) documented in pharmacy history
    Action if not metPrior authorization required
    Ubrelvy triptan lookback window
    Window length120 days
    Applies toEvidence of a generic triptan fill in Independent Health prescription history to route Ubrelvy online
    Action if not metPrior authorization required
    Uloric allopurinol lookback window
    Lookback window90 days
    Required prior fillAllopurinol documented in pharmacy history to route febuxostat (Uloric) online
    Action if not metPrior authorization required
    • Confirm step-therapy status on the member formulary (ST note) prior to prescribing or dispensing.
    • If step requirements are not met, prior authorization or supporting documentation may be required.
    Prior Authorization

    Opioid ER/Fentanyl Prior Authorization

    Opioid ER/Fentanyl Prior Authorization: A prescription for listed extended-release opioid or fentanyl products will process online only if the patient's Independent Health prescription history documents that narcotic medications were filled within the previous 120 days. If the pharmacy profile does not show such fills within 120 days, prior authorization is required.

    • Affected products include multiple extended-release opioid formulations (examples listed in source).
    • Pharmacy must check Independent Health prescription history for narcotic fills within prior 120 days before processing.
    • If required history is absent, the prescriber must submit a prior authorization with clinical justification.
    Documentation Required

    Pharmacy Must Reference Independent Health Prescription History

    Pharmacy Operational Requirement: Pharmacies must reference the member's Independent Health prescription history when determining whether a prescription meets automatic processing triggers (e.g., prior fills, concurrent therapies). When the profile does not meet the documented criteria, prior authorization is required.

    • Always verify Independent Health prescription history for trigger conditions (diagnosis or prior medication fills) before dispensing.
    • If the pharmacy profile lacks the required history, advise prescriber to submit PA documentation.
    Note

    Product Index and Presentation Examples

    Product Index / Presentation Examples: The document includes an index of affected products and examples of product presentations (strengths and packaging) for pharmacy and provider reference. This section is informational and does not itself list prior authorization details beyond indicating which products are subject to the rules above.

    • Index entries list product presentations (e.g., strengths, formulations, pen/auto-injector volumes, tablet strengths).
    • Use the index to identify specific NDC/product presentations when submitting prior authorization or checking step-therapy applicability.
    • The index itself does not change prior authorization criteria — it maps products to the applicable rules described above.
    Prior Authorization

    GLP-1 Antidiabetic Prior Authorization Trigger

    GLP-1 Antidiabetic Prior Authorization Trigger: Operational trigger — a GLP-1 antidiabetic prescription is allowed to process online when the member's Independent Health prescription history documents either a diagnosis of type 2 diabetes or prior fills of an oral antidiabetic (excluding metformin) within 130 days. Absent this documentation, the pharmacy must obtain prior authorization.

    • Trigger lookback window: 130 days for prior oral antidiabetic fills (excluding metformin).
    • Trigger conditions: documented type 2 diabetes diagnosis OR documented prior oral antidiabetic use (excluding metformin).
    • If neither condition is present in the Independent Health prescription history, submit prior authorization.
    Note

    No Other Explicit Provider Actions

    No Additional Provider Actions Stated: Within these source chunks there are no other explicit provider actions beyond verifying prescription history, following step-therapy protocols, and submitting prior authorization when criteria are not met.

    • If further documentation or clinical information is required, the PA process will request it; no other discrete actions are specified in these excerpts.

    Uloric initial therapy requirement

    Step: try allopurinol: Evidence of an allopurinol fill within 90 days is required in pharmacy history before febuxostat (Uloric) will route online.90 days
    Action if not metPrior authorization required
    generic triptan examples
    ExamplesSumatriptan, naratriptan, rizatriptan
    ContextGeneric triptan fills documented within 120 days are required to route Ubrelvy online
    Action if not metPrior authorization required for Ubrelvy